MEMPHIS, TENN. - July 28, 2014 - Medtronic, Inc. (MDT) announces that it has received approval from the U.S. Food and Drug Administration (FDA) to market the PRESTIGE® LP Cervical Disc System for the ...
Two-Level Use of Prestige LP Cervical Disc Exhibited Statistical Superiority in Overall Success at 24 Months Compared to Patients Treated with Two-Level Fusion DUBLIN - July 18, 2016 - Medtronic plc ...
PRESTIGE® LP Cervical Disc System / Courtesy: Medtronic, Inc. Medtronic, Inc.’s Prestige LP cervical disc has received FDA PMA (premarket application) approval. The company announced on July 28, 2014, ...
MEMPHIS, TENN. - July 28, 2014 - Medtronic, Inc. (NYSE: MDT) announces that it has received approval from the U.S. Food and Drug Administration (FDA) to market the PRESTIGE® LP Cervical Disc System ...
The PRESTIGE® LP Cervical Disc is Medtronic's Third Clinically-Proven Artificial Cervical Disc to Receive FDA Approval MEMPHIS, TENN. - July 28, 2014 - Medtronic, Inc. (NYSE: MDT) announces that it ...
The FDA recently approved the Medtronic Prestige LP Cervical System for treating degenerative disc disease at two adjacent vertebral levels (between C3 and C7). The device is said to be Medtronic’s ...
Medtronic released results of a seven-year follow-up study in which the two-level Prestige LP Cervical Disc was compared to 2-level anterior cervical discectomy and fusion. The Prestige LP Disc is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results